Andra AP-fonden’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$97.3M Buy
397,877
+55,772
+16% +$13M 1.16% 12
2025
Q4
$70.8M Buy
342,105
+140,505
+70% +$27.8M 0.87% 18
2025
Q3
$37.4M Sell
201,600
-7,100
-3% -$1.22M 0.48% 53
2025
Q2
$31.9M Buy
208,700
+94,100
+82% +$14.5M 0.44% 77
2025
Q1
$19M Sell
114,600
-35,200
-23% -$5.51M 0.31% 115
2024
Q4
$21.7M Sell
149,800
-240,300
-62% -$37.2M 0.35% 92
2024
Q3
$63.2M Sell
390,100
-71,100
-15% -$11.3M 0.93% 8
2024
Q2
$67.4M Buy
461,200
+272,200
+144% +$40.5M 1.13% 6
2024
Q1
$29.9M Buy
+189,000
New +$30.1M 0.53% 48
2023
Q3
Sell
-51,000
Closed -$8.44M 420
2023
Q2
$8.44M Sell
51,000
-7,900
-13% -$1.28M 0.21% 175
2023
Q1
$9.13M Buy
58,900
+16,700
+40% +$2.7M 0.24% 145
2022
Q4
$7.46M Sell
42,200
-18,700
-31% -$3.23M 0.23% 158
2022
Q3
$9.95M Sell
60,900
-6,500
-10% -$1.1M 0.33% 52
2022
Q2
$12M Buy
+67,400
New +$12M 0.34% 41
2021
Q4
$15.4M Sell
90,200
-14,100
-14% -$2.31M 0.31% 61
2021
Q3
$16.8M Buy
104,300
+8,800
+9% +$1.5M 0.35% 25
2021
Q2
$15.7M Sell
95,500
-8,900
-9% -$1.47M 0.32% 32
2021
Q1
$17.2M Sell
104,400
-100
-0.1% -$16.2K 0.38% 14
2020
Q4
$16.4M Buy
104,500
+53,100
+103% +$7.84M 0.36% 14
2020
Q3
$7.65M Sell
51,400
-3,400
-6% -$503K 0.21% 161
2020
Q2
$7.71M Buy
54,800
+5,900
+12% +$860K 0.22% 95
2020
Q1
$6.41M Buy
48,900
+11,600
+31% +$1.65M 0.23% 54
2019
Q4
$5.44M Buy
37,300
+5,100
+16% +$692K 0.16% 325
2019
Q3
$4.17M Sell
32,200
-3,700
-10% -$487K 0.12% 444
2019
Q2
$5M Sell
35,900
-2,700
-7% -$374K 0.14% 362
2019
Q1
$5.4M Buy
+38,600
New +$5.17M 0.16% 321
2018
Q3
$10.9M Buy
78,800
+8,200
+12% +$1.09M 0.28% 33
2018
Q2
$8.57M Buy
70,600
+17,200
+32% +$2.15M 0.23% 101
2018
Q1
$6.84M Sell
53,400
-301,896
-85% -$40.8M 0.18% 224
2017
Q4
$49.6M Sell
355,296
-13,754
-4% -$1.92M 1.13% 2
2017
Q3
$48M Buy
369,050
+16,450
+5% +$2.18M 1.12% 2
2017
Q2
$46.6M Sell
352,600
-7,405
-2% -$945K 1.15% 2
2017
Q1
$44.8K Sell
360,005
-11,495
-3% -$1.37M 1.05% 3
2016
Q4
$42.8M Sell
371,500
-25,600
-6% -$2.96M 1.17% 2
2016
Q3
$46.9M Buy
397,100
+8,700
+2% +$1.06M 1.26% 2
2016
Q2
$47.1M Buy
388,400
+400
+0.1% +$45.5K 1.2% 2
2016
Q1
$42M Sell
388,000
-26,100
-6% -$2.7M 1.1% 2
2015
Q4
$42.5M Sell
414,100
-7,100
-2% -$714K 1.22% 1
2015
Q3
$39.3M Buy
421,200
+7,600
+2% +$735K 1.15% 1
2015
Q2
$40.3M Sell
413,600
-35,700
-8% -$3.58M 1.16% 2
2015
Q1
$45.2M Sell
449,300
-127,000
-22% -$12.9M 1.28% 1
2014
Q4
$60.3M Sell
576,300
-72,300
-11% -$7.62M 1.4% 1
2014
Q3
$69.1M Sell
648,600
-5,700
-0.9% -$591K 1.62% 1
2014
Q2
$68.5M Buy
654,300
+87,900
+16% +$8.88M 1.5% 1
2014
Q1
$55.6M Hold
566,400
1.28% 5
2013
Q4
$51.9M Buy
566,400
+1,600
+0.3% +$147K 1.22% 3
2013
Q3
$49M Buy
564,800
+28,200
+5% +$2.53M 1.25% 4
2013
Q2
$46.1M Buy
+536,600
New +$45.5M 1.2% 5

Other funds holding JNJ

Andra AP-fonden's JNJ Position: Q1 2026 in Review

Andra AP-fonden increased its Johnson & Johnson (JNJ) stake by 16% in Q1 2026, buying an estimated $13M and bringing the position to 397,877 shares worth $97.3M. The position accounts for 1.16% of the portfolio, ranked #12.

Andra AP-fonden first reported a position in JNJ in Q2 2013 and has held it in 48 quarters since. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Andra AP-fonden held 397,877 shares of Johnson & Johnson worth $97.3M as of Q1 2026.
  • Andra AP-fonden bought 55,772 Johnson & Johnson shares in Q1 2026, an estimated $13M.
  • Johnson & Johnson made up 1.16% of Andra AP-fonden's portfolio in Q1 2026, its #12 holding.
  • Andra AP-fonden first reported a position in Johnson & Johnson in Q2 2013 and has held it in 48 quarters since.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Andra AP-fonden's 13F filing for Q1 2026, filed 8 May 2026.